Figure 3
ctDNA dynamics of patient 9 (type I) with long observation time after the first disease progression.
The details of panels are the same as those in Fig. 2. Abbreviations are as follows: DOC, docetaxel; AMR, amurubicin.
Figure 3 | Scientific Reports
